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Abstract
The trunsored model, which is a new incomplete data model regarded as a unified
model of the censored and truncated models in lifetime analysis, can not only estimate
the ratio of the fragile population to the mixed fragile and durable populations or the
cured and fatal mixed populations, but also test a hypothesis that the ratio is equal to a
prescribed value with ease.
Since SARS showed a severe case fatality ratio, our concern is to know such a case
fatality ratio as soon as possible after a similar outbreak begins. The epidemiological
determinants of spread of SARS can be dealt with as the probabilistic growth curve models,
and the parameter estimation procedure for the probabilistic growth curve models may
similarly be treated as the lifetime analysis. Thus, we try to do the parameter estimation
to the SARS cases for the infected cases, fatal cases, and cured cases here, as we usually do
it in the lifetime analysis. Using the truncated data models to the infected and fatal cases
with some censoring time, we may estimate the total (or final) numbers of the patients and
deaths, and the case fatality ratio may be estimated by these two numbers. We may also
estimate the case fatality ratio using the numbers of the patients and recoveries, but this
estimate differs from that using the numbers of the patients and deaths, especially when
the censoring time is located at early stages.
To circumvent this inconsistency, we propose a mixed trunsored model, an extension
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of the trunsored model, which can use the data of the patients, deaths, and recoveries
simultaneously. The estimate of the case fatality ratio and its confidence interval are
easily obtained in a numerical sense.
This paper mainly treats the case in Hong Kong. The estimated epidemiological
determinants of spread of SARS, fitted to the infected, fatal, and cured cases in Hong
Kong, could be the logistic distribution function among the logistic, lognormal, gamma,
and Weibull models. Using the proposed method, it would be appropriate that the SARS
case fatality ratio is roughly estimated to be 17% in Hong Kong. Worldwide, it is roughly
estimated to be about 12-18%, if we consider the safety side without the Chinese case.
Unlike the questionably small confidence intervals for the case fatality ratio using the
truncated models, the case fatality ratio in the proposed model provides a reasonable
confidence interval.
Keywords: truncated data; grouped data; generalized logistic distribution; case fatality
rate; case fatality ratio; mortality rate; case survival ratio; bootstrap.
1. Introduction
A. Motivation and Objectives
WHO reports Severe Acute Respiratory Syndrome (SARS) outbreak as shown in
Appendix (see also [42, 43]). During almost a month from 21 February the SARS virus
spread without isolation of probable patients. Taking into account of the short incubation
period which is estimated as five to eight days (see [22]), it appears that the virus raged
for more than a month without prevention. The number of probable patients appeared to
grow exponentially in this period, and then the control of the human-to-human chain of
transmission of the disease suppressed the growth rate of spreading. It may be considered
that only one seed made a typical epidemic growth curve of the disease spread. Our
concern is first what the appropriate probability distribution for the curve is; the logistic,
the lognormal, the gamma, or the Weibull distribution may be fitted to the data provided
by WHO ([41]).
As SARS showed a severe case fatality ratio (abbreviated CFR here like in [20], but
other terms such as case fatality rate in reference [7, 35, 36] or mortality rate in reference
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[40] are also used), our second concern is to know the ratio as soon as possible after the
outbreak began. Since WHO opens the numbers of probable cases and the fatal cases
to the public day by day, we can estimate the CFR by some censoring time T using the
conditional likelihoods for both the probable and fatal cases; this approach is considered
to be the truncated model approach. However, WHO, in addition to these two data cases,
gave us the recovery (or cured) cases, which would be the fruitful information for the
parameter estimation of the underlying probability distributions; we can also estimate the
CFR using the probable and cured cases. We propose here a new estimation method for
the parameters of the underlying distributions and the CFR using the three data sets of
probable, fatal, and cured cases together. The trunsored model approach (Hirose [17, 18])
can do this, but the traditional truncated model approach cannot.
The objective of the introduction of the trunsored model was to do hypothesis tests
easily (Hirose [17, 18]). This purpose may also be realized in our situation that we use the
three data sets together. However, we do not go deeply into such a direction in this paper;
we introduce the estimation methods of the underlying probability distribution parameters
and of the CFR.
B. Statistical Background
In some lifetime estimation problems, short-term survivors and long-term survivors are
mixed: for example, Boag [3], Farewell [10], and Goldman [12] discussed the proportion of
patients cured by a particular treatment; Anscombe [1] treated market penetration; Maltz
and McCleary [26], and Steinhurst [31] discussed recidivism; Meeker [27] and Hirose [17,
18] applied the model to integrated circuit reliability. Maller and Zhou [25], Zhou and
Maller [37], Sun and Zhou [32], Vu, Maller, and Zhou [34], Peng, Dear, and Carriere [29]
discussed the model as long-term survivors. Tsodikov, Ibrahim, and Yakovlev recently
review the cure rates [33]. In such cases, r events within T are observed from n samples,
but the ratio, pm, of the long-term survivors to the mixed populations is unknown. If
n is unknown, the truncated model (e.g., Johnson, Kotz and Balakrishnan [21]; Meeker
and Escobar [28]; Wallace, Blischke and Murthy [39]; and Klein and Moeschberger [23])
could be applied. However, the information n may be useful in our situation; one of the
advantages to adopt this kind of model is described as the application of the likelihood
ratio test in Hirose [17, 18].
The epidemiological determinants of spread of SARS can be dealt with as the prob-
abilistic growth curve models [24], and the parameter estimation procedure for the prob-
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abilistic growth curve models may similarly be treated as the lifetime analysis. Thus, we
try to do the parameter estimation to the SARS cases for the infected cases, fatal cases,
and cured cases here, as we usually do it in the lifetime analysis. To estimate the CFR
caused by SARS, the truncated model approach using the infected and fatal growth curves
may be fine. However, the recovery rate by the same approach using the infected and
cured growth curves may not be consistent with the CFR obtained by using the infected
and fatal cases. Thus, the truncated approach cannot have such consistency. A new ap-
proach proposed here, the mixed trunsored model, can have, however. Donnelly et al. [7]
computed the CFR with the admission-to-death and admission-to-discharge distributions,
but the proposed method shown here used the infected case distribution in addition.
2. Trunsored model
2.1 Single Trunsored Model
We define a cumulative probability distribution function, H(t;ψ), which is a linear
combination of F (t; θ) and G(t;φ) given by
H(t;ψ) = sF (t; θ) + (1− s)G(t;φ),
(t ≥ 0, −∞ < s <∞),
(1)
with a combination parameter s, and the corresponding pdf, h(t;ψ), for H is also defined
h(t;ψ) =sf(t; θ) + (1− s)g(t;φ). (2)
Then, the likelihood function for the combined model can be expressed in the form
L(ψ) = {1−H(T ;ψ)}n−r ·
r∏
i=1
h(ti;ψ), (3)
where ti denotes the observed times that events occurred. If we assume that the censoring
time, T , is smaller than the left endpoint, T0, of G(t) such that
G(T ) = 0, g(ti) = 0, (ti < T < T0, i = 1, · · · , n), (4)
i.e., G implies the long-term survivors, then L(ψ)→ Lts(θ, s), where
Lts(θ, s) = {1− sF (T ; θ)}n−r ·
r∏
i=1
{sf(ti; θ)}. (5)
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This is the likelihood for the trunsored model in Hirose [17, 18].
For the sake of comparison, we define two additional likelihood functions for the
censored model and the truncated model as
Lc(θ) = {1− F (T ; θ)}n−r ·
r∏
i=1
f(ti; θ), (6)
Lt(θ) =
r∏
i=1
{f(ti; θ)/F (T ; θ)}. (7)
2.2 Mixed Trunsored Model
We consider cumulative probability distribution functions, Fj (j = 1, · · · , J), with
trunsored likelihoods such that
Ljts(θj , sj) = {1− sjFj(T ; θj)}nj−rj ·
rj∏
i=1
{sjfj(ti; θj)}, (8)
under the restriction that
ζ(s1, · · · , sJ) = 0, (9)
where nj (j = 1, · · · , J) are the number of samples, and rj (j = 1, · · · , J) are the number
of observed events. If restriction (9) is not imposed, the likelihood equations in (8) can
be solved independently; with the restriction, however, we need to solve the likelihood
equations simultaneously. In SARS applications, F1, F2, and F3 may correspond to the
infected case, fatal case, and cured case growth curves, respectively; restriction (9) implies
that the probable cases are divided into exactly two categories: the fatal and the recovered
cases as in (10)
s1 = s2 + s3. (10)
Then, we can estimate the parameters, sj and θj , by maximizing the likelihood function
for the mixed trunsored model,
Lmts(θ, s) =
J∏
j=1
Ljts(θj , sj). (11)
If the time of event is not observed and the number of events in some period, e.g.,
from Ti to Ti+1, are observed instead, we consider the grouped data model such that
Lts(θ, s) = {1− sF (T ; θ)}n−r ·
k∏
i=1
[s{F (Ti+1)− F (Ti)}]. (12)
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In SARS case, Ti to Ti+1 may be one day, two days, or three days.
3. Probability distributions
We consider four typical probability distribution models for the growth curves: the
generalized logistic distribution (GL) [44], the extended lognormal distribution (ELN)
[15], the extended gamma distribution (EGM) [14], and the generalized extreme-value
distribution (GEV) [13], to allow the negative and positive skewness in the distribution
functions [16]; the number of parameters are three including the location parameter.
The logistic distribution with two parameter is often used as the growth model because
this distribution is derived from the differential equation for the biological models; the
generalized logistic curve [44], also known as Richards’ curve [30], is a widely-used and
flexible function for growth modeling by including the shape parameter in the model. The
probability density function and the cumulative distribution function for GL are expressed
by,
fGL(x;σ, µ, β) =
β exp(−z)
σ{1 + exp(−z)}β+1 , (13)
FGL(x;σ, µ, β) =
1
{1 + exp(−z)}β ,
(z = (x− µ)/σ, −∞ < x <∞, −∞ < µ <∞, σ > 0, β > 0).
(14)
This distribution is negatively skewed when β < 1, and is positively skewed when β > 1.
It is symmetric when β = 1, as is known to two parameter logistic distribution.
As mentioned in section 1, probabilistic growth curves of the spread of SARS fitted
to the infected cases, fatal cases, and cured cases can similarly be treated to the lifetime
distributions, we deal with three typical probability distribution models used in the lifetime
analysis. The density functions for ELN, EGM, and GEV are expressed by,
fELN (x;σ, µ, λ) =
1√
2piσ{1 + λz} exp
(
− [log{1 + λz}]
2
2λ2
)
, (15)
fEGM (x;σ, µ, λ) =
1
σ|λ|Γ(λ−2)
(
1 + λz
λ2
)λ−2−1
exp
{
−
(
1 + λz
λ2
)}
, (16)
fGEV (x;σ, µ, λ) =
1
σ
(
1 + λz
)1/λ−1 exp{−(1 + λz)1/λ}, (17)
with
σ > 0, λ 6= 0, 1 + λz > 0, z = x− µ
σ
. (18)
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These three distribution models are the extension models from the log-normal (LN), gamma
(GM), and Weibull (WB) distributions, respectively, with densities,
fLN (x;α, τ, γ) =
1√
2pi(x− α)τ exp
[
−
{log(x−αγ )}2
2τ2
]
,
(x > α, τ > 0, γ > 0)
(19)
fGM (x;α, β, γ) =
1
γΓ(β)
(
x− α
γ
)β−1
exp
{
−
(
x− α
γ
)}
,
(x ≥ α, β > 0, γ > 0),
(20)
fWB(x; η, β, γ) =
β
η
(
x− γ
η
)β−1
exp
{
−
(
x− γ
η
)β}
,
(x ≥ γ, η > 0, β > 0).
(21)
4. Applications to SARS
4.1 WHO Data
WHO opened the daily number of probable cases from March 17, 2003, to July 11,
2003, to the public [41]; On September 26, 2003, summary of probable SARS cases with
onset of illness from November 1, 2002, to July 31, 2003, is additionally opened. As
mentioned earlier, the outbreak began by only one seed in Hong Kong; the growth curves
for infected cases, fatal cases, and cured cases in Hong Kong are smooth and natural
comparing to those in other districts such as China, Taiwan and Canada; for example in
Canada, two successive asynchronous outbreaks occurred. Here, we deal with a rather
simple case such as the case in Hong Kong as a primary analysis. The cumulative numbers
of infected patients, deaths, and recovered persons from March 17, 2003, to July 11, 2003,
are shown in Table 1.
4.2 Appropriate Distribution Model using the Truncated Model
To find the most appropriate probability distribution model in the four models intro-
duced previously, we first fit the four models to SARS data for the infected, fatal, and
cured cases. Using the truncated model of (7) with censoring time on July 11, 2003, the
maximum values of the log-likelihood functions are obtained as shown in Table 2, result-
ing that the generalized logistic model has the largest likelihood values for the infected,
7
fatal, and cured cases. The difference of the likelihood values between the log-normal and
the gamma is not so large; however, the difference between the generalized logistic and
the log-normal and that between the generalized logistic and the Weibull are significantly
large. We use the generalized logistic model from now on.
The estimated cumulative probability distribution functions of the generalized logis-
tic distribution and the empirical distribution functions for the patients, fatal, and cured
cases are shown in Figure 1; circles, triangles, and squares in the figure express the em-
pirical functions for patients, fatal, and cured cases, respectively, and the dashed lines are
estimated distribution functions. It appears that the shapes of the three probability dis-
tribution functions are almost the same; only the location parameter seems to be different.
We therefore may assume that the shape and scale parameters for these three distribu-
tions are the same; under such an assumption, the maximum likelihood estimates for the
parameters in (13) and (14) are σˆ = 12.559, λˆ = 3.2697, µˆ1 = 3.9973 (infected case),
µˆ2 = 25.316 (fatal case), µˆ3 = 25.343 (cured case), and the corresponding log-likelihood
value is −13532.9, which is smaller than the value of sum of the three independently ob-
tained maximum log-likelihood values, −13515.0, for the patients, fatal, and cured cases,
where time t = 0 is set to the date on March 16, 2003; see Table 2. Here, we use the
notation of θj = (σ, λ, µj)T .
(INSERT TABLE 1, 2 AND FIGURE 1 ABOUT HERE.)
4.3 Case Fatality Ratio by the Truncated Model Approach
The observed numbers of the patients and deaths are considered to be grouped (day
by day) and right truncated. By computing both the total expected numbers of patients
and deaths, it seems that we can estimate the CFR as shown below, but the estimate
seems to be questionable.
(a) Inconsistency of the estimate
Using the truncated model likelihood to the infected patients, we can estimate the
total number of patients, m1, in the future. If the estimated parameter is θˆ1, then mˆ1 can
be estimated by
mˆ1 = r1/F1(T1; θˆ1), (22)
where, T1 is the censoring time. Similarly, the total number of fatal cases, mˆ2, and the total
number of cured cases, mˆ3, are also calculated easily, if parameters, θˆ2 and θˆ3, are obtained.
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The CFR, pf , and the case survival ratio (abbreviated CSR here, ps, are estimated by
pˆf = mˆ2/mˆ1, pˆs = mˆ3/mˆ1, (23)
where the CSR is defined by the number of survivors divided by the number of patients in
this paper.
As mentioned above, the best fit probability distribution model is the generalized
logistic distribution, thus we may obtain the CFR by applying the truncated models with
the generalized logistic distribution to the infected and fatal cases. When we set the
censoring time, T = T1 = T2, on July 11, 2003, and we suppose that the scale and
shape parameters are the same for patients, deaths, and recoveries, then we can obtain
the estimates, mˆ1 = 1, 755.71 and mˆ2 = 298.66; thus, the CFR, pˆf , becomes 17.01%. If
we use the estimate of the total number of cured cases, mˆ3 = 1, 436.17, then the CSR
pˆs = 81.80% (i.e., pˆf = 18.20%) is obtained. Here, these two ratios under the truncated
model approach are obtained by solving the simultaneous likelihood equations,
∂ logLt(θj)
∂θj
= 0, (j = 1, 2, 3), (24)
where θj = (σ, λ, µj)T because we supposed that σj = σ, λj = λ, (j = 1, 2, 3); the number
of unknown parameters are 5 (σ, λ, µ1, µ2, µ3). However, the sum of the CFR, obtained by
using the fatal and infected cases, and the CSR, obtained by using the cured and infected
cases, is not equal to 1. If we set the censoring time on May 25, 2003, this discrepancy
becomes markedly large; we obtain mˆ1 = 1, 740.23, mˆ2 = 278.90, and mˆ3 = 1, 346.46, then
the estimated CFR and the CSR are, pˆf = 16.03% and pˆs = 77.37%. It would be crucial
to get rid of this inconsistency even in earlier stages, i.e., the censoring time is earlier.
(b) Paradox of the error
Using the bootstrap method [8, 9] with 1,000 resampling, we can obtain the confidence
interval for the CFR. When we set the censoring time on May 25, 2003, the 95% confidence
interval for the CFR is computed as 13.60% ≤ pf ≤ 17.40%. This value seems to be
acceptable. If the censoring time is set to the right far enough, e.g., on July 11, 2003,
however, the estimated number of patients, mˆ1 = 1, 755.71, and the estimated number
of deaths, mˆ2 = 298.66, become very close to the observed numbers of patients, 1755,
and deaths, 298, by that time; in other resampling cases, the results are much the same.
Then,the 95% confidence interval for the CFR is computed as 16.90% ≤ pf ≤ 17.09%
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(heavily skewed as shown in Figure 2). Such very small confidence intervals are also
reported elsewhere ([6]). After the outbreaks are completely ceased, e.g., based on data as
of the December 31, 2003, the CFR might be computed with extremely small variance, if we
use the conditional likelihood. For example, in Hong Kong, the CFR would become to be
just 299/1, 755(= 17.0370370...%) if no new patients, deaths, and recoveries were observed
at all after December 31, 2003; similarly in Taiwan, just 37/346(= 10.69...%) is expected;
in Singapore, just 33/238(= 13.86...%); in Canada, just 43/251(= 17.13...%). However,
the number of deaths in Hong Kong, for example, may differ from that in other situations;
for example, the number of deaths 299 could be 301 by chance; then, the CFR would be
changed to some other value (301/1, 755(= 17.15099715...% > 17.09%)). Assuming that
the CFR of SARS is supposed to be some constant value, then the number of deaths would
be varied by chance. The CFRs in various districts could be fluctuated, but they would
be covered by some interval, say [0.1, 0.2]. This is the reason why I think that the very
small confidence intervals obtained by using the truncated model are paradoxical.
(INSERT FIGURE 2 ABOUT HERE.)
4.4 Mixed Trunsored Model Approach and the Case Fatality Ratio
Based on the truncated model, inconsistent estimates for the CFR and paradoxical
confidence intervals are computed. To circumvent these flaws, we next use the proposed
method, the mixed trunsored model.
All the patients are divided exactly into two categories: fatal cases and cured cases.
This means that pf + ps = 1. This restriction cannot be imposed to the truncated model
approach straightforwardly. The trunsored model approach using (8-12), however, can do
this; we only need to impose the restriction that s3 = s1 − s2. The CFR and the CSR are
calculated by
pf = s2/s1, ps = s3/s1 = 1− pf . (25)
Setting nj (j = 1, 2, 3) to some numbers, e.g., the actual population in Hong Kong (this
is about 6,810,000 persons in 2003 [4]), the estimated parameters, under the assumption
that σj = σ (j = 1, 2, 3) and λj = λ (j = 1, 2, 3), are σˆ = 12.560, λˆ = 3.2708, µˆ1 = 3.9911,
µˆ2 = 25.310, µˆ3 = 25.337, sˆ1 = 0.21147×10−3, sˆ2 = 0.44223×10−4, and the corresponding
log-likelihood value is −46, 577 when we set the censoring time on July 11, 2003; thus,
pˆf = 1− pˆs = 17.30% is obtained. If we set the censoring time on May 25, 2003, the CFR
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is computed as pˆf = 17.16%, which is almost the same value as that when the censoring
time is July 11, 2003. The values of the estimates, sˆj (j = 1, 2, 3), are not important by
themselves; they change their values by setting nj (j = 1, 2, 3) to other values, but pˆf and
pˆs are hardly affected by these values.
The CFR under the mixed trunsored model approach with 7 (σ, λ, µ1, µ2, µ3, s1,
s2) unknown parameters are shown in Figure 3 when we vary the censoring time T . The
estimated value of the CFR at time t in the figure means that the estimate is obtained
under the assumption that the censoring time T is equal to t. In the truncated model,
the CFRs are obtained by two estimates: one is by using the numbers of the patients and
deaths, and the other is by using the the numbers of the patients and recoveries. In Figure
3, these two CFRs under the truncated model approach are also shown. We can see that
the estimated CFRs in the mixed trunsored model keep almost a constant value in a wide
range of censoring time, while the CFRs in the truncated model do not, as mentioned
above.
(INSERT FIGURE 3 ABOUT HERE.)
The 95% confidence intervals for the estimates of the CFR using the bootstrap method
are computed as 15.51% ≤ pf ≤ 19.13% and 13.73% ≤ pf ≤ 19.04% when the censoring
time is set to on July 11, 2003, and on May 25, 2003, respectively. The corresponding stan-
dard deviations, SD(pˆf ), are 0.92% and 1.35%, respectively. These values are considered
to be reasonable and acceptable; see the next section. The histogram of the bootstrapped
estimates for the CFR, when the censoring time is on July 11, 2003, is shown in Figure
4. The frequency distributions of the bootstrapped estimates for the CFRs at various
censoring times are shown in Figure 5. We can see that the confidence interval of the CFR
at earlier estimating stage, e.g., 70th day from March 17, 2003, i.e., May 25, 2003, is wider
than that at the final stage, but they are not so different from each other.
(INSERT FIGURES 4 AND 5 ABOUT HERE.)
5. Discussion
5.1 Robustness against the Amount of nj
The confidence intervals for the CFR are obtained under the assumption that nj =
6, 810, 000 (j = 1, 2, 3); other values of nj (j = 1, 2, 3) will provide different confidence
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intervals, but the confidence intervals are not affected much as long as the values of nj
(j = 1, 2, 3) are not so small. For example, using nj = 681, 000 (j = 1, 2, 3), the 95%
confidence intervals for the CFR are computed as 15.52% ≤ pf ≤ 19.11% and 13.64% ≤
pf ≤ 19.20% when the censoring time is set to on July 11, 2003, and on May 25, 2003,
respectively.
5.2 Approximate Standard Deviation of the Case Fatality Ratio
The variance of a ratio X/Y is approximately obtained by
V ar
(X
Y
)
≈
(E(X)
E(Y )
)2
×
(V ar(X)
E(X)2
− 2Cov(X,Y )
E(X)E(Y )
+
V ar(Y )
E(Y )2
)
, (26)
where X and Y are random variables [2]. We assume that X = s2 and Y = s1. When
the censoring time is late enough, then E(X) and E(Y ) become s2 and s1, and V ar(X)
and V ar(Y ) become approximately s2(1− s2)/n2 and s1(1− s1)/n1. Using Cov(X,Y ) =
ρ
√
V ar(X)V ar(Y ), (26) is approximately reduced to
V ar(pˆf ) ≈ pˆ2f ×
( 1
nˆp
− 2ρ√
nˆpnˆd
+
1
nˆd
)
, (27)
where nˆp and nˆd are the estimates for the numbers of patients and deaths; ρ denotes the
correlation coefficient, Corr(X,Y ), between X and Y . Since nˆp and nˆd are estimated
as 1, 741.3 and 301.16, the approximate standard deviation of the CFR, SD(pˆf ), varies
0.00582 ≤ SD(pˆf ) ≤ 0.01079 according to the value of the correlation coefficient, 0 ≤ ρ ≤
1, which is consistent to the standard deviation obtained by the bootstrap in the mixed
trunsored model.
Using the number of patients, deaths, and recoveries by the date of the December 31,
2003 in various infected districts, approximate CFRs and their 95% confidence intervals
are computed by (27); they are shown in Table 3 and Figure 6. In the figure, the solid
and dashed lines express the 95% confidence intervals when ρ = 0 and when ρ = 1,
respectively. A very rough interval for the CFR, [12, 18]%, includes points in the 95%
confidence intervals of Canada, Hong Kong, Taiwan, Singapore, and Viet Nam, but does
not include points in the 95% confidence interval of China. According to [41], 325 cases
have been discarded in Taiwan since 11 July, 2003 because Laboratory information was
insufficient or incomplete for 135 discarded cases, of which 101 died. World-wide, the CFR
of about 9.6% (including Chinese cases) has been announced by media. However, this
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estimate should be treated cautiously; this is caused mainly by the Chinese CFR, and this
value, about 6.6%, is very different from those in other countries. There would be reasons
for such a very different value of the CFR. One reason would be that Chinese infected
cases were counted circumspectly. However, a noticeable reference is also seen (see [5]),
in which Chinese medicine is found to improve the case survival rate in the treatment of
SARS. In any case, it would be appropriate that the SARS CFR is estimated without the
Chinese case if we consider the safety side. In such a case, it is roughly estimated to be
about 12-18%, worldwide.
(INSERT TABLE 3 AND FIGURE 6 ABOUT HERE.)
6. Concluding remarks
The epidemiological determinants of spread of SARS can be dealt with as the proba-
bilistic growth curve models, and the parameter estimation procedure for the probabilistic
growth curve models may similarly be treated as the lifetime analysis. Thus, we try to do
the parameter estimation to the SARS cases for the infected cases, fatal cases, and cured
cases, here, as we usually do it in the lifetime analysis. The truncated data model approach
using the infected and fatal cases can estimate the case fatality ratio of the disease, but
it also estimates the case fatality ratio using the numbers of the patients and recoveries;
these estimates differ from each other in early censoring time stage. To circumvent this
inconsistency, and to obtain reasonable estimates, the mixed trunsored model, which is an
extension of the censored and truncated unified model, is found to be useful in estimating
the case fatality ratio of SARS, when we use the data of the patients, deaths, and recov-
eries together. Using the proposed method, it would be appropriate that the SARS case
fatality ratio is roughly estimated to be about 12-18% worldwide, if we consider the safety
side without the Chinese case. Unlike the questionably small confidence intervals for the
case fatality ratio using the truncated models, the case fatality ratio in the proposed model
provides a reasonable confidence interval.
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Appendix
WHO (2003) reports SARS outbreak as follows (see [42, 43]):
First recognized as a global threat in mid-March 2003, SARS was successfully con-
tained in less than four months. On 5 July 2003, WHO reported that the last human chain
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of transmission of SARS had been broken. While much has been learned about this syn-
drome since March 2003, including its causation by a new coronavirus (SARS-CoV), our
knowledge about the epidemiology and ecology of SARS coronavirus infection and of this
disease remains limited. Resurgence of SARS remains a distinct possibility and does not
allow for complacency.
The earliest cases are now known to have occurred in mid-November in Guangdong
Province, China. SARS was first carried out into the world at large on 21 February, 2003,
when an infected medical doctor from Guangdong checked into room 911 on the 9th floor
of the Metropole Hotel in Hong Kong. That single hotel floor became the setting for the
international spread of SARS. At least 14 guests and visitors carried the virus with them to
the hospital systems of Toronto, Hong Kong, Viet Nam, and Singapore. The earliest and
most severe outbreaks in Toronto, Hong Kong, Viet Nam, and Singapore were all seeded
by visitors to the hotel. At that time, prior to the first global alert issued by WHO on
12 March 2003, no one was aware that a severe new disease, capable of rapidly spreading
in hospitals, had emerged. Hospital staff responding to the earliest cases failed to protect
themselves from infection as they aggressively fought to save lives. As a result, the disease
rapidly spread within hospitals, infecting staff, other patients, and visitors, and then spilled
out into the larger community as family members and their close contacts became infected.
As the outbreaks grew in size, the number of exported cases rose, with 30 countries and
areas eventually reporting cases.
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Table 1. Cumulative number of probable cases.
( (a) from March 17 2003 to May 24 2003)
date patients deaths recoveries date patients deaths recoveries
3.17 95 1 – 4.21 1,402 94 436
3.18 123 1 – 4.22 1,434 99 461
3.19 150 5 – 4.23 1,458 105 522
3.20 173 6 – 4.24 1,488 109 567
3.21 203 6 – 4.25 1,510 115 614
3.22 222 7 – 4.26 1,527 121 632
3.24 260 10 – 4.28 1,557 138 710
3.25 286 10 – 4.29 1,572 150 759
3.26 316 10 – 4.30 1,589 157 791
3.27 367 10 – 5.1 1,600 162 834
3.28 425 10 – 5.2 1,611 170 878
3.29 470 10 – 5.3 1,621 179 898
3.31 530 13 – 5.5 1,637 187 930
4.1 685 16 – 5.6 1,646 193 958
4.2 708 16 – 5.7 1,654 204 984
4.3 734 17 – 5.8 1,661 208 1,008
4.4 761 17 – 5.9 1,667 210 1,015
4.5 800 20 – 5.10 1,674 212 1,035
4.7 883 23 – 5.12 1,683 218 1,066
4.8 928 25 – 5.13 1,689 225 1,090
4.9 970 27 – 5.14 1,698 227 1,128
4.10 998 30 154 5.15 1,703 234 1,160
4.11 1,059 32 169 5.16 1,706 238 1,171
4.12 1,108 35 215 5.17 1,710 243 1,191
4.14 1,190 47 229 5.19 1,714 251 1,213
4.15 1,232 56 243 5.20 1,718 253 1,229
4.16 1,268 61 257 5.21 1,719 255 1,237
4.17 1,297 65 272 5.22 1,722 258 1,247
4.18 1,327 69 322 5.23 1,724 260 1,255
4.19 1,358 81 363 5.24 1,724 262 1,266
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Table 1. Cumulative number of probable cases.
( (b) from May 26 2003 to July 11 2003)
date patients deaths recoveries date patients deaths recoveries
5.26 1,726 267 1,276 7.4 1,755 298 1,430
5.27 1,728 269 1,285 7.7 1,755 298 1,430
5.28 1,730 270 1,295 7.8 1,755 298 1,430
5.29 1,732 273 1,302 7.9 1,755 298 1,431
5.30 1,736 274 1,304 7.10 1,755 298 1,431
5.31 1,739 278 1,310 7.11 1,755 298 1,433
6.2 1,746 282 1,319
6.3 1,747 283 1,326
6.4 1,748 283 1,339
6.5 1,748 284 1,343
6.6 1,750 286 1,350
6.9 1,753 288 1,365
6.10 1,754 290 1,368
6.11 1,754 290 1,368
6.12 1,755 291 1,377
6.13 1,755 293 1,380
6.16 1,755 295 1,386
6.17 1,755 295 1,387
6.18 1,755 295 1,393
6.19 1,755 296 1,396
6.20 1,755 296 1,403
6.23 1,755 296 1,411
6.24 1,755 296 1,417
6.25 1,755 296 1,419
6.26 1,755 296 1,419
6.27 1,755 296 1,422
6.30 1,755 298 1,429
7.1 1,755 298 1,429
7.2 1,755 298 1,429
7.3 1,755 298 1,429
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Table 2. Log-likelihood values in the four probability distribution models.
Based on data as of the June 11, 2003, and using the truncated model.
logistic log-normal gamma Weibull
infected −6816.40 > −6817.65 > −6819.00 > −6827.28
fatal −1228.72 > −1230.46 > −1230.54 > −1233.55
cured −5469.89 > −5472.55 > −5475.31 > −5482.64
total −13515.0 > −13520.7 > −13524.8 > −13543.5
Table 3. Approximate case fatality ratios and their standard deviations.
Based on data as of the December 31, 2003.
Country cases deaths case fatality ratio (%) standard deviation (%)
ρ = 0 ρ = 1
Canada 251 43 17.13 2.83 1.53
China 5,327 349 6.55 0.36 0.26
Hong Kong 1,755 299 17.04 1.07 0.58
Taiwan 346 37 10.69 1.85 1.18
Singapore 238 33 13.87 2.58 1.51
Viet Nam 63 5 7.94 3.69 2.55
world-wide 8,096 774 9.56 0.36 0.24
According to [41], 325 cases have been discarded in Taiwan since 11 July 2003
because Laboratory information was insufficient or incomplete for 135 discarded
cases, of which 101 died.
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Figure 1. Empirical probability distributions for  the patients,
deaths, and  recoveries, along with the corresponding
estimated probability distributions.
circles: infected empirical,
triangles: fatal empirical,
squares: cured empirical.
dashed lines: estimated probability distributions.
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Figure 2.   Bootstrapped estimates of the case fatality ratio in the
                 truncated model.
                 The censoring time is set on July 11, 2003.
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Estimated case fatality ratios.
filled circles: mixed trunsored model using patients, deaths, and
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triangles: truncated model using patients and deaths,
squares: truncated model using patients and recoveries.
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Figure 4.   Bootstrapped estimates of the case fatality ratio in the mixed
                  trunsored model.
                 The censoring time is set on July 11, 2003.
0
20
40
60
80
100
120
140
160
180
.14 .15 .16 .17 .18 .19 .2 .21
case fatality ratio
fre
qu
en
cy
17
16
15
14
18
19
20
case fatality ratio
time
frequency
50
60
70
80
90
100
110
Figure 5 Bootstrapped frequency for the case fatality ratio in
the mixed trunsored model.
Figure 6.   Estimated case fatality ratios and their approximate 95%
                  confidence intervals
       Solid line: when correlation coefficiet between numbers of
                   patients and deaths = 0
       Dashed line: when correlation coefficiet between numbers of
                   patients and deaths = 1
       A band [12,18]% includes points in 95% confidence intervals
                   in Canada, Hong Kong, Taiwan, Singapore, and Viet Nam.
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